SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAPUTO, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.238
AS - Asia 3.972
EU - Europa 3.969
SA - Sud America 698
AF - Africa 65
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.953
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.109
PL - Polonia 1.753
SG - Singapore 1.578
CN - Cina 1.196
BR - Brasile 588
IT - Italia 543
UA - Ucraina 429
DE - Germania 425
HK - Hong Kong 411
TR - Turchia 307
VN - Vietnam 236
GB - Regno Unito 230
RU - Federazione Russa 138
FI - Finlandia 105
SE - Svezia 102
ID - Indonesia 76
MX - Messico 61
CA - Canada 57
AR - Argentina 56
FR - Francia 55
NL - Olanda 48
IN - India 43
BE - Belgio 35
ZA - Sudafrica 31
AT - Austria 26
BD - Bangladesh 21
EC - Ecuador 21
JP - Giappone 20
ES - Italia 18
IQ - Iraq 17
LT - Lituania 17
CZ - Repubblica Ceca 15
RO - Romania 11
CO - Colombia 10
IR - Iran 9
IL - Israele 8
MA - Marocco 8
KE - Kenya 7
PY - Paraguay 7
SA - Arabia Saudita 7
TN - Tunisia 7
IE - Irlanda 6
PK - Pakistan 6
UZ - Uzbekistan 6
VE - Venezuela 6
AU - Australia 5
CH - Svizzera 5
EG - Egitto 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
LB - Libano 4
PE - Perù 4
AL - Albania 3
DZ - Algeria 3
JM - Giamaica 3
KZ - Kazakistan 3
OM - Oman 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
GT - Guatemala 2
KH - Cambogia 2
KR - Corea 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
LK - Sri Lanka 1
MG - Madagascar 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PW - Palau 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 16.953
Salva come PNG Salva come JPEG
Città #
Warsaw 1.750
Fairfield 947
Ashburn 802
Woodbridge 756
Singapore 723
Houston 556
Beijing 456
Santa Clara 424
Hong Kong 410
Jacksonville 395
Seattle 377
Chandler 362
Wilmington 343
Ann Arbor 332
Cambridge 328
Izmir 236
Ferrara 202
Princeton 172
Nanjing 161
New York 143
Dallas 134
Los Angeles 121
San Diego 107
Munich 92
Milan 68
Ho Chi Minh City 63
Shanghai 63
The Dalles 63
Jakarta 56
Hanoi 45
Bologna 44
São Paulo 43
Boardman 42
Nanchang 41
Mexico City 39
Hebei 36
London 36
Shenyang 36
Brussels 35
Tianjin 35
Dong Ket 34
Buffalo 33
Jiaxing 32
Chicago 29
Changsha 27
Dearborn 27
Rome 27
Nuremberg 25
Falls Church 24
Brooklyn 23
Rio de Janeiro 23
Hefei 22
Norwalk 22
San Francisco 22
Falkenstein 21
Jinan 21
Mountain View 21
Turku 21
Boston 20
Phoenix 20
Tokyo 20
Helsinki 18
Montreal 18
Moscow 18
Orange 18
Belo Horizonte 17
Redwood City 17
Stockholm 17
Amsterdam 16
Atlanta 15
Kunming 15
San Mateo 15
Modena 14
Porto Alegre 14
Chennai 13
Frankfurt am Main 13
Johannesburg 13
Auburn Hills 12
Brno 12
Des Moines 12
Ningbo 12
Poplar 12
Toronto 12
Da Nang 11
Ottawa 11
Ankara 10
Goiânia 10
Haiphong 10
Taizhou 10
Washington 10
Denver 9
Ferrara di Monte Baldo 9
Manchester 9
Orem 9
Salt Lake City 9
Augusta 8
Brasília 8
Columbus 8
Guarulhos 8
San Bonifacio 8
Totale 12.068
Salva come PNG Salva come JPEG
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 336
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 310
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 294
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS tat-based vaccines 270
Candidate HIV-1 Tat vaccine development: From basic science to clinical trials 265
HIV-1 tat addresses dendritic cells to induce a predominant th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection 246
The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: Findings in a cohort of HIV-1 seroconverters 241
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys 238
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 223
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 222
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 215
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 213
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 206
Nanoparticles for delivery of a pharmacologically active agent 194
Recombinant herpes simplex virus and uses therefor 191
null 183
null 179
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 179
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 169
null 167
Episomal DNA of a BK virus variant in a human insulinoma 163
Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice 161
Containment of infection in Tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6Pcy243 160
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 158
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 157
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 157
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 157
Transformation of hamster kidney cells by fragments of BK virus DNA 154
Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model 154
Cooperation in oncogenesis between BK virus early region gene and the activated human c-Harvey RAS oncogene 152
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment 148
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 147
Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells 143
Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane 141
Complex associates of plasmid DNA and a novel class of block copolymers with PEG and cationic segments as new vectors for gene delivery 134
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 131
Recent Advances In The Development Of HIV-1 Tat-Based Vaccines 129
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 129
The tat gene and protein of the human immunodeficiency virus type 1. 128
DNA immunization with HIV-1 tat mutated in the transactivation domain induces humoral and cellular immune response against wild-type Tat 126
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19 124
The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells 124
Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2 122
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 121
Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination 116
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 115
The HIV-1 tat gene as a target for gene therapy and analysis of its role in cell proliferation 114
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles 114
The HIV-1 regulatory genes tat and rev as targets for gene therapy 113
null 113
Reexamination of the coding potential of the HTLV-1 pX region 112
Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens 112
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 112
Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat protein 112
Induction of anti-Tat immune response in mice following inoculation of plasmid DNA expressing HIV-tat mutant genes. 111
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 111
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans 111
null 110
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes 110
Induzione di una risposta immune in topi immunizzati con DNA plasmidici codificanti due mutanti transdominanti negativi del gene tat di HIV-1. 107
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P) 107
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 106
Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes 106
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment 106
null 104
null 103
Expression of hepatitis B surface antigen in human cells by a recombinant BK virus DNA vector 103
Presenza del virus BK in sarcomi di Kaposi. 102
Co-operation in cell transformation between BK virus and the human c-Harvey-ras oncogene 102
The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein 102
Naïve CD8+ T-Cells Engage a Versatile Metabolic Program Upon Activation in Humans and Differ Energetically From Memory CD8+ T-Cells 102
null 101
Formation of oligomeric free BK virus DNA is required for tandem integration of viral genomes into cellular DNA 101
Inhibition of HIV-1 tat activity correlates with down-regulation of bcl-2 and results in reduction of angiogenesis and oncogenicity 101
Functional polymeric nano/microparticles for surface adsorption and delivery of protein and DNA vaccines 101
Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application 99
Core-shell microspheres by dispersion polymerization as promising delivery systems for proteins 98
New BK virus episomal vector for complementary DNA expression in human cells 97
Hpv-specific systemic antibody responses and memory b cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with cervarix and gardasil in adolescent and young adult women in vaccination programs in Italy 97
null 95
The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells 95
HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials 95
Transformation of hamster kidney cells by a fragment of BK virus DNA containing the entire early region 94
Pentosan Polysulfate as an Inhibitor of Extracellular HIV-1 Tat 94
Constitutive expression of hiv-1 tat protein in human jurkat t cells using a bk virus vector 94
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 94
null 94
Antiretroviral Therapy Partially Restores Phenotypic and Metabolic Immunosenescence Features of T Cells in Hiv Infected Individuals 93
Interaction of Sp1 transcription factor with HIV-1 Tat protein: Looking for cellular partners 93
Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules 92
null 91
Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication 91
The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice 91
DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination 91
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 91
null 90
null 90
Vaccine development for herpes simplex viruses: A commentary of special issue editors 88
null 87
null 86
Totale 13.621
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.856
Totale 88.944
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.146 0 0 0 0 111 152 109 218 72 236 153 95
2021/20221.313 38 110 73 81 29 53 68 113 61 115 106 466
2022/2023918 138 36 53 101 130 115 58 96 111 8 46 26
2023/2024636 63 79 33 23 43 139 25 36 19 17 11 148
2024/20252.893 91 69 237 99 329 222 113 108 459 402 462 302
2025/20263.598 830 310 740 1.001 717 0 0 0 0 0 0 0
Totale 17.200